Solu Therapeutics
PrivateLast Round
Series A
Apr 9, 2025
Est. Valuation
$100M
Total Funding Raised
$72M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Solu Therapeutics is a biotechnology company that develops a cytotoxicity-targeting chimera platform designed to eliminate disease-driving cells, providing oncology therapeutics that help reduce the risk of inflammatory and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solu Therapeutics Comparables
Compare Solu Therapeutics with similar companies based on industry and business-model similarity.
Solu Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 9, 2025 | ||||
| Seed | Aug 1, 2023 |
Key People
Founding team and executive leadership
Solu Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hengdian Group Capital | Series A |
| A. M. Pappas & Associates | Series A |
| DCVC Bio | Series A, Seed |
| Santé Ventures | Series A, Seed |
| Alexandria Venture Investments | Series A, Seed |
| Astellas Venture Management | Series A, Seed |
| The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Program (TAP) | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 53% MoM.
- Jun 16, 2025
Enda Moran appointed as the new Chief Operating Officer.
Solu Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Solu Therapeutics's valuation, stock price, and market status.